(Q34617485)

3 August 2017

1 reference

title

Safety considerations of fluoroquinolones in the elderly: an update (English)

1 reference

3 August 2017

Ralf Stahlmann

1

1 reference

3 August 2017

Hartmut Lode

series ordinal

2

1 reference

3 August 2017

publication date

1 March 2010

1 reference

3 August 2017

1 reference

3 August 2017

volume

27

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

193-209

1 reference

Is age an independent risk factor of adverse drug reactions in hospitalized medical patients?

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11531490-000000000-00000

Ciprofloxacin and sparfloxacin penetration into human brain tissue and their activity as antagonists of GABAA receptor of rat vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11531490-000000000-00000

Moxifloxacin: update and perspectives after 8 years of usage

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11531490-000000000-00000

Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11531490-000000000-00000

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec

21 January 2018

1 reference

12 December 2020

Nephrotoxicity and purpura associated with levofloxacin

1 reference

12 December 2020

Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes

1 reference

12 December 2020

Toxicity of quinolone antimicrobial agents

1 reference

12 December 2020

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

1 reference

12 December 2020

Tendon disorders with fluoroquinolones

1 reference

12 December 2020

Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.

1 reference

12 December 2020

A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia

1 reference

12 December 2020

A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context

1 reference

12 December 2020

Images in clinical medicine. Quinolone-associated rupture of the Achilles' tendon

1 reference

12 December 2020

Outpatient gatifloxacin therapy and dysglycemia in older adults

1 reference

12 December 2020

Ultrastructure of Achilles tendon from rats after treatment with fleroxacin

1 reference

12 December 2020

Gatifloxacin: a review of its use in the management of bacterial infections

1 reference

12 December 2020

Quinolone-induced arthropathy: exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics

1 reference

12 December 2020

Ciprofloxacin crystal nephropathy.

1 reference

12 December 2020

Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998.

1 reference

12 December 2020

Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections

1 reference

12 December 2020

Bilateral hydronephrosis from ciprofloxacin induced crystalluria and stone formation

1 reference

12 December 2020

Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats

1 reference

12 December 2020

Pefloxacin-induced achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen

1 reference

12 December 2020

Cardiotoxicity of fluoroquinolones

1 reference

12 December 2020

Clinical pharmacodynamics of quinolones

1 reference

12 December 2020

An elderly patient with fluoroquinolone-associated achilles tendinitis

1 reference

12 December 2020

Quinolone-induced cartilage lesions are not reversible in rats

1 reference

12 December 2020

Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoni

1 reference

12 December 2020

Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats

1 reference

12 December 2020

Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model

1 reference

12 December 2020

Clostridium difficile-associated diarrhoea in patients with community-acquired lower respiratory infection being treated with levofloxacin compared with beta-lactam-based therapy

1 reference

12 December 2020

A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia

1 reference

12 December 2020

Achilles tendon rupture associated with combination therapy of levofloxacin and steroid in four patients and a review of the literature

1 reference

12 December 2020

Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy

1 reference

12 December 2020

Effect of quinolones on intestinal ecology

1 reference

12 December 2020

Ciprofloxacin strongly inhibits clozapine metabolism: two case reports

1 reference

12 December 2020

Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly

1 reference

12 December 2020

Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects

1 reference

12 December 2020

Seizures associated with fluoroquinolones

1 reference

12 December 2020

Levofloxacin-induced granulomatous interstitial nephritis

1 reference

12 December 2020

Gemifloxacin for community-acquired pneumonia

1 reference

12 December 2020

Antimicrobial safety: focus on fluoroquinolones

1 reference

12 December 2020

The safety profile of moxifloxacin and other fluoroquinolones in special patient populations

1 reference

12 December 2020

Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction

1 reference

12 December 2020

Gemifloxacin for the treatment of respiratory tract infections: in vitro susceptibility, pharmacokinetics and pharmacodynamics, clinical efficacy, and safety

1 reference

12 December 2020

Safety concerns with fluoroquinolones

1 reference

12 December 2020

Role of newer fluoroquinolones in lower respiratory tract infections

1 reference

12 December 2020

Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet

1 reference

12 December 2020

Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.

1 reference

12 December 2020

Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors

1 reference

12 December 2020

Ciprofloxacin. A review of its pharmacological profile and therapeutic use in the elderly

1 reference

12 December 2020

Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora

1 reference

12 December 2020

Fluoroquinolone toxicity profiles: a review focusing on newer agents

1 reference

12 December 2020

Fluoroquinolones in the elderly: safety considerations

1 reference

12 December 2020

Quinolones in the aged

1 reference

12 December 2020

Possible ciprofloxacin-induced acute cholestatic jaundice

1 reference

12 December 2020

Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens.

1 reference

12 December 2020

Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study

1 reference

12 December 2020

What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?

1 reference

12 December 2020

Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies

1 reference

12 December 2020

Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG.

1 reference

12 December 2020

Clinical toxicological aspects of fluoroquinolones

1 reference

12 December 2020

Achilles tendinitis associated with fluoroquinolones

1 reference

12 December 2020

Retrospective analysis of the safety profile of oral moxifloxacin in elderly patients enrolled in clinical trials

1 reference

12 December 2020

Telithromycin and the FDA: implications for the future

1 reference

12 December 2020

Impact of a fluoroquinolone restriction policy in an elderly population

1 reference

12 December 2020

Potassium current antagonist properties and proarrhythmic consequences of quinolone antibiotics.

1 reference

12 December 2020

Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption

1 reference

12 December 2020

Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections

1 reference

12 December 2020

Brain tissue penetration of ciprofloxacin following a single intravenous dose

1 reference

12 December 2020

Tendons and fluoroquinolones. Unresolved issues

1 reference

12 December 2020

Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data

1 reference

12 December 2020

Drug interactions during therapy with three major groups of antimicrobial agents

1 reference

12 December 2020

Classification of fluoroquinolones

1 reference

12 December 2020

Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections

1 reference

12 December 2020

Fluoroquinolone-induced renal failure

1 reference

12 December 2020

Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors

1 reference

12 December 2020

Gatifloxacin: a review of its use in the treatment of bacterial infections in the US.

1 reference

12 December 2020

Clinical practice. Antibiotic-associated diarrhea

1 reference

12 December 2020

Torsades de pointes associated with fluoroquinolones

1 reference

12 December 2020

10.2165/11531490-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1032403668

0 references

1 reference